

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | COPI coating of Golgi vesicle (GO:0048205) | 5.80436607 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 5.80436607 |
| 3 | protein retention in ER lumen (GO:0006621) | 5.19106516 |
| 4 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 5.11471437 |
| 5 | cysteine metabolic process (GO:0006534) | 4.62106034 |
| 6 | sulfur amino acid catabolic process (GO:0000098) | 4.61042825 |
| 7 | serine family amino acid catabolic process (GO:0009071) | 4.53741729 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.47177310 |
| 9 | L-phenylalanine catabolic process (GO:0006559) | 4.47177310 |
| 10 | L-phenylalanine metabolic process (GO:0006558) | 4.43913210 |
| 11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.43913210 |
| 12 | vitamin transmembrane transport (GO:0035461) | 4.12934618 |
| 13 | cell adhesion mediated by integrin (GO:0033627) | 4.11726731 |
| 14 | homocysteine metabolic process (GO:0050667) | 4.09532514 |
| 15 | barbed-end actin filament capping (GO:0051016) | 4.09363357 |
| 16 | skin morphogenesis (GO:0043589) | 4.07255861 |
| 17 | aromatic amino acid family catabolic process (GO:0009074) | 4.05893757 |
| 18 | basement membrane organization (GO:0071711) | 4.03586046 |
| 19 | alpha-linolenic acid metabolic process (GO:0036109) | 4.01781367 |
| 20 | urate metabolic process (GO:0046415) | 3.97796337 |
| 21 | amino-acid betaine metabolic process (GO:0006577) | 3.95451589 |
| 22 | glyoxylate metabolic process (GO:0046487) | 3.93906555 |
| 23 | protein localization to endosome (GO:0036010) | 3.92980672 |
| 24 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.91906049 |
| 25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.90931087 |
| 26 | protein carboxylation (GO:0018214) | 3.90931087 |
| 27 | protein maturation by protein folding (GO:0022417) | 3.88427723 |
| 28 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.86896162 |
| 29 | glycine metabolic process (GO:0006544) | 3.85474047 |
| 30 | biotin metabolic process (GO:0006768) | 3.77827188 |
| 31 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.76150118 |
| 32 | pantothenate metabolic process (GO:0015939) | 3.76101079 |
| 33 | serine family amino acid metabolic process (GO:0009069) | 3.75487843 |
| 34 | tryptophan catabolic process (GO:0006569) | 3.73346683 |
| 35 | indole-containing compound catabolic process (GO:0042436) | 3.73346683 |
| 36 | indolalkylamine catabolic process (GO:0046218) | 3.73346683 |
| 37 | pinocytosis (GO:0006907) | 3.72922331 |
| 38 | negative regulation of fibrinolysis (GO:0051918) | 3.70816950 |
| 39 | regulation of protein activation cascade (GO:2000257) | 3.68440494 |
| 40 | lysine metabolic process (GO:0006553) | 3.63799586 |
| 41 | lysine catabolic process (GO:0006554) | 3.63799586 |
| 42 | peptidyl-proline hydroxylation (GO:0019511) | 3.63153318 |
| 43 | tryptophan metabolic process (GO:0006568) | 3.62769400 |
| 44 | kynurenine metabolic process (GO:0070189) | 3.62212688 |
| 45 | regulation of complement activation (GO:0030449) | 3.59022239 |
| 46 | bile acid biosynthetic process (GO:0006699) | 3.54729525 |
| 47 | regulation of cholesterol homeostasis (GO:2000188) | 3.49451756 |
| 48 | serine family amino acid biosynthetic process (GO:0009070) | 3.48552455 |
| 49 | complement activation, alternative pathway (GO:0006957) | 3.44073111 |
| 50 | valine metabolic process (GO:0006573) | 3.40835481 |
| 51 | actin filament depolymerization (GO:0030042) | 3.37975453 |
| 52 | protein hydroxylation (GO:0018126) | 3.36181381 |
| 53 | epithelial cell-cell adhesion (GO:0090136) | 3.33378928 |
| 54 | folic acid transport (GO:0015884) | 3.33173457 |
| 55 | hemidesmosome assembly (GO:0031581) | 3.32478993 |
| 56 | extracellular fibril organization (GO:0043206) | 3.31062467 |
| 57 | regulation of extracellular matrix disassembly (GO:0010715) | 3.27264994 |
| 58 | high-density lipoprotein particle remodeling (GO:0034375) | 3.26892098 |
| 59 | apoptotic cell clearance (GO:0043277) | 3.26093482 |
| 60 | cellular glucuronidation (GO:0052695) | 3.25503147 |
| 61 | regulation of fibrinolysis (GO:0051917) | 3.25045809 |
| 62 | plasma lipoprotein particle clearance (GO:0034381) | 3.23086543 |
| 63 | urea cycle (GO:0000050) | 3.22899948 |
| 64 | urea metabolic process (GO:0019627) | 3.22899948 |
| 65 | reverse cholesterol transport (GO:0043691) | 3.20804572 |
| 66 | aromatic amino acid family metabolic process (GO:0009072) | 3.20324381 |
| 67 | fatty acid beta-oxidation (GO:0006635) | 3.17369265 |
| 68 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.16960733 |
| 69 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.16960733 |
| 70 | folic acid metabolic process (GO:0046655) | 3.15144653 |
| 71 | bile acid metabolic process (GO:0008206) | 3.14977988 |
| 72 | vitamin transport (GO:0051180) | 3.14977504 |
| 73 | regulation of triglyceride catabolic process (GO:0010896) | 3.14795653 |
| 74 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.12139552 |
| 75 | 2-oxoglutarate metabolic process (GO:0006103) | 3.10257366 |
| 76 | triglyceride homeostasis (GO:0070328) | 3.10101632 |
| 77 | acylglycerol homeostasis (GO:0055090) | 3.10101632 |
| 78 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.10021811 |
| 79 | drug transmembrane transport (GO:0006855) | 3.09660301 |
| 80 | fatty acid oxidation (GO:0019395) | 3.08765226 |
| 81 | uronic acid metabolic process (GO:0006063) | 3.06924599 |
| 82 | glucuronate metabolic process (GO:0019585) | 3.06924599 |
| 83 | adhesion of symbiont to host (GO:0044406) | 3.06584115 |
| 84 | alpha-amino acid catabolic process (GO:1901606) | 3.06254474 |
| 85 | lipid oxidation (GO:0034440) | 3.05951737 |
| 86 | bile acid and bile salt transport (GO:0015721) | 3.05396401 |
| 87 | carnitine metabolic process (GO:0009437) | 3.04204596 |
| 88 | stress fiber assembly (GO:0043149) | 3.03941409 |
| 89 | modified amino acid transport (GO:0072337) | 3.03126482 |
| 90 | cell-substrate junction assembly (GO:0007044) | 3.02865507 |
| 91 | regulation of cholesterol esterification (GO:0010872) | 3.02113752 |
| 92 | fibrinolysis (GO:0042730) | 3.01192141 |
| 93 | membrane protein ectodomain proteolysis (GO:0006509) | 3.00974523 |
| 94 | cellular amino acid catabolic process (GO:0009063) | 2.98403403 |
| 95 | positive regulation of receptor recycling (GO:0001921) | 2.98270113 |
| 96 | low-density lipoprotein particle clearance (GO:0034383) | 2.96020503 |
| 97 | S-adenosylmethionine metabolic process (GO:0046500) | 2.95281945 |
| 98 | fibril organization (GO:0097435) | 2.94715328 |
| 99 | endodermal cell differentiation (GO:0035987) | 2.94272434 |
| 100 | regulation of cholesterol metabolic process (GO:0090181) | 2.93979529 |
| 101 | nitrogen cycle metabolic process (GO:0071941) | 2.93165878 |
| 102 | proline biosynthetic process (GO:0006561) | 2.92437315 |
| 103 | desmosome organization (GO:0002934) | 2.92428531 |
| 104 | protein-lipid complex remodeling (GO:0034368) | 2.91362294 |
| 105 | macromolecular complex remodeling (GO:0034367) | 2.91362294 |
| 106 | plasma lipoprotein particle remodeling (GO:0034369) | 2.91362294 |
| 107 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.91012890 |
| 108 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.90102768 |
| 109 | fatty acid catabolic process (GO:0009062) | 2.88928702 |
| 110 | regulation of early endosome to late endosome transport (GO:2000641) | 2.87117486 |
| 111 | sulfur amino acid metabolic process (GO:0000096) | 2.86827678 |
| 112 | 4-hydroxyproline metabolic process (GO:0019471) | 2.85611805 |
| 113 | drug transport (GO:0015893) | 2.85110793 |
| 114 | semaphorin-plexin signaling pathway (GO:0071526) | 2.84988397 |
| 115 | response to mercury ion (GO:0046689) | 2.84830830 |
| 116 | negative regulation of cholesterol transport (GO:0032375) | 2.84813735 |
| 117 | negative regulation of sterol transport (GO:0032372) | 2.84813735 |
| 118 | L-serine metabolic process (GO:0006563) | 2.83788222 |
| 119 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.82825334 |
| 120 | lipoprotein metabolic process (GO:0042157) | 2.82728166 |
| 121 | vesicle coating (GO:0006901) | 2.82232721 |
| 122 | substrate-dependent cell migration (GO:0006929) | 2.81287487 |
| 123 | organic acid catabolic process (GO:0016054) | 2.81272386 |
| 124 | carboxylic acid catabolic process (GO:0046395) | 2.81272386 |
| 125 | ethanol oxidation (GO:0006069) | 2.80839549 |
| 126 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.79858497 |
| 127 | branched-chain amino acid catabolic process (GO:0009083) | 2.79834129 |
| 128 | positive regulation of extracellular matrix organization (GO:1903055) | 2.79257232 |
| 129 | cellular copper ion homeostasis (GO:0006878) | 2.78554361 |
| 130 | amyloid precursor protein catabolic process (GO:0042987) | 2.77970855 |
| 131 | fructose metabolic process (GO:0006000) | 2.77478321 |
| 132 | cellular ketone body metabolic process (GO:0046950) | 2.77106054 |
| 133 | regulation of plasminogen activation (GO:0010755) | 2.76269034 |
| 134 | cholesterol homeostasis (GO:0042632) | 2.75912569 |
| 135 | platelet degranulation (GO:0002576) | 2.75086792 |
| 136 | sterol homeostasis (GO:0055092) | 2.74508469 |
| 137 | cellular modified amino acid catabolic process (GO:0042219) | 2.74358429 |
| 138 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.73818037 |
| 139 | monocarboxylic acid catabolic process (GO:0072329) | 2.73736250 |
| 140 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.73304966 |
| 141 | type B pancreatic cell proliferation (GO:0044342) | 2.73259248 |
| 142 | cofactor transport (GO:0051181) | 2.72677192 |
| 143 | muscle cell migration (GO:0014812) | 2.72101197 |
| 144 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.71321455 |
| 145 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.70099601 |
| 146 | hypotonic response (GO:0006971) | 2.69483911 |
| 147 | adherens junction assembly (GO:0034333) | 2.67127495 |
| 148 | adhesion of symbiont to host cell (GO:0044650) | 2.65040521 |
| 149 | virion attachment to host cell (GO:0019062) | 2.65040521 |
| 150 | endocardial cushion development (GO:0003197) | 2.64080916 |
| 151 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.63903983 |
| 152 | positive regulation of osteoblast proliferation (GO:0033690) | 2.62788043 |
| 153 | hyaluronan catabolic process (GO:0030214) | 2.62076116 |
| 154 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.61060977 |
| 155 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.60828520 |
| 156 | regulation of extracellular matrix organization (GO:1903053) | 2.60106492 |
| 157 | positive regulation of nuclease activity (GO:0032075) | 2.57026418 |
| 158 | regulation of apoptotic cell clearance (GO:2000425) | 2.56977531 |
| 159 | chondrocyte proliferation (GO:0035988) | 2.56951780 |
| 160 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.54496577 |
| 161 | endothelial cell morphogenesis (GO:0001886) | 2.51701678 |
| 162 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.50016945 |
| 163 | negative regulation of fatty acid transport (GO:2000192) | 2.49816046 |
| 164 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.49587872 |
| 165 | cell-substrate adherens junction assembly (GO:0007045) | 2.49025330 |
| 166 | focal adhesion assembly (GO:0048041) | 2.49025330 |
| 167 | regulation of metalloenzyme activity (GO:0048552) | 2.48894712 |
| 168 | melanin biosynthetic process (GO:0042438) | 2.48855707 |
| 169 | mesodermal cell differentiation (GO:0048333) | 2.48349474 |
| 170 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.45479828 |
| 171 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.44660395 |
| 172 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.44402448 |
| 173 | embryo implantation (GO:0007566) | 2.43781742 |
| 174 | wound healing, spreading of cells (GO:0044319) | 2.42335826 |
| 175 | wound healing, spreading of epidermal cells (GO:0035313) | 2.42152459 |
| 176 | cell-cell junction maintenance (GO:0045217) | 2.39816293 |
| 177 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.39381624 |
| 178 | negative regulation of anoikis (GO:2000811) | 2.38819513 |
| 179 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.38410617 |
| 180 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.38308924 |
| 181 | positive regulation of pseudopodium assembly (GO:0031274) | 2.37934109 |
| 182 | COPII vesicle coating (GO:0048208) | 2.37036653 |
| 183 | glucose 6-phosphate metabolic process (GO:0051156) | 2.36892295 |
| 184 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.35374918 |
| 185 | pentose-phosphate shunt (GO:0006098) | 2.34848083 |
| 186 | cortical actin cytoskeleton organization (GO:0030866) | 2.32095054 |
| 187 | membrane raft organization (GO:0031579) | 2.31539104 |
| 188 | extracellular matrix disassembly (GO:0022617) | 2.31050854 |
| 189 | collagen fibril organization (GO:0030199) | 2.30432836 |
| 190 | glucose catabolic process (GO:0006007) | 2.30033321 |
| 191 | endothelial cell chemotaxis (GO:0035767) | 2.29609111 |
| 192 | ER-nucleus signaling pathway (GO:0006984) | 2.28242805 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.94270601 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.12188748 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.75766736 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.62735147 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.96116558 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.44931472 |
| 7 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.18826908 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.18024235 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.98802277 |
| 10 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.91943097 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.81292642 |
| 12 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.62798490 |
| 13 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.61906219 |
| 14 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.33350194 |
| 15 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.17618386 |
| 16 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.16728097 |
| 17 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.01161133 |
| 18 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.94068069 |
| 19 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.91109658 |
| 20 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.90693310 |
| 21 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.86401764 |
| 22 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.85947379 |
| 23 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.79084703 |
| 24 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.75505990 |
| 25 | GATA1_22025678_ChIP-Seq_K562_Human | 1.71858780 |
| 26 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.69079487 |
| 27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.61156410 |
| 28 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.60645824 |
| 29 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.59840068 |
| 30 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.59310629 |
| 31 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.56945690 |
| 32 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.56444113 |
| 33 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.56376136 |
| 34 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.53609375 |
| 35 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.53270547 |
| 36 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.51264945 |
| 37 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.49529958 |
| 38 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.47854251 |
| 39 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.47595071 |
| 40 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.47049994 |
| 41 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.43796635 |
| 42 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.43399125 |
| 43 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.38961255 |
| 44 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.38789495 |
| 45 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.36001511 |
| 46 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.33522314 |
| 47 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.33416682 |
| 48 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.31693568 |
| 49 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.30186874 |
| 50 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.29354662 |
| 51 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.27751355 |
| 52 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.26999972 |
| 53 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.25716300 |
| 54 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.25421909 |
| 55 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.23097400 |
| 56 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.23097400 |
| 57 | ATF3_27146783_Chip-Seq_COLON_Human | 1.21502282 |
| 58 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.20220505 |
| 59 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.19526881 |
| 60 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.16214510 |
| 61 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.15813633 |
| 62 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.15486851 |
| 63 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.12391508 |
| 64 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.11466221 |
| 65 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.11202113 |
| 66 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.10409916 |
| 67 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.09569867 |
| 68 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.09025694 |
| 69 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.08083934 |
| 70 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.07923103 |
| 71 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.07344739 |
| 72 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.07091893 |
| 73 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.05906912 |
| 74 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.05835448 |
| 75 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.05641451 |
| 76 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.05586091 |
| 77 | * POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.05042144 |
| 78 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.04963861 |
| 79 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.04861190 |
| 80 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.04460692 |
| 81 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.04187025 |
| 82 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03281037 |
| 83 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.03128550 |
| 84 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.02554523 |
| 85 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02436836 |
| 86 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.02148039 |
| 87 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.01681107 |
| 88 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.01296185 |
| 89 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.99712584 |
| 90 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.99683334 |
| 91 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.99241422 |
| 92 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.97853077 |
| 93 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.97431706 |
| 94 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.97397461 |
| 95 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.95547543 |
| 96 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.95360485 |
| 97 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.95017088 |
| 98 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.94960858 |
| 99 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.94542659 |
| 100 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.94468243 |
| 101 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.93075051 |
| 102 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.92983005 |
| 103 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.92520395 |
| 104 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.91199310 |
| 105 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.91081087 |
| 106 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.91060740 |
| 107 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90099161 |
| 108 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.89561515 |
| 109 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.88681058 |
| 110 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88094721 |
| 111 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.87610872 |
| 112 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.86244107 |
| 113 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.86244107 |
| 114 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.85427413 |
| 115 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85118507 |
| 116 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.85044532 |
| 117 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.84456331 |
| 118 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.83691555 |
| 119 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.83240486 |
| 120 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.82745233 |
| 121 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.81785402 |
| 122 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.81287859 |
| 123 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.79807384 |
| 124 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.78712104 |
| 125 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.76135252 |
| 126 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.76089592 |
| 127 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.74946375 |
| 128 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.74796617 |
| 129 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.74697864 |
| 130 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.73794080 |
| 131 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.71173215 |
| 132 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.70517138 |
| 133 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.70189940 |
| 134 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.70141250 |
| 135 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.69720242 |
| 136 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.69714932 |
| 137 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.69346688 |
| 138 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.68890668 |
| 139 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.68624378 |
| 140 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.68572578 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.86644453 |
| 2 | MP0005360_urolithiasis | 4.51387079 |
| 3 | MP0005365_abnormal_bile_salt | 3.81729461 |
| 4 | MP0009840_abnormal_foam_cell | 3.62998004 |
| 5 | MP0005257_abnormal_intraocular_pressure | 3.62624038 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.55855498 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 2.93969377 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 2.60694744 |
| 9 | MP0003252_abnormal_bile_duct | 2.58076907 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.43832424 |
| 11 | MP0008438_abnormal_cutaneous_collagen | 2.43585083 |
| 12 | MP0005332_abnormal_amino_acid | 2.37480428 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.32934787 |
| 14 | MP0005171_absent_coat_pigmentation | 2.30246104 |
| 15 | MP0003705_abnormal_hypodermis_morpholog | 2.29185353 |
| 16 | MP0004858_abnormal_nervous_system | 2.20376036 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 2.09019834 |
| 18 | MP0005409_darkened_coat_color | 2.06902716 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 2.06453911 |
| 20 | MP0003195_calcinosis | 2.05179854 |
| 21 | MP0003091_abnormal_cell_migration | 1.96650645 |
| 22 | MP0001666_abnormal_nutrient_absorption | 1.86610554 |
| 23 | MP0010368_abnormal_lymphatic_system | 1.77678571 |
| 24 | MP0005623_abnormal_meninges_morphology | 1.73269951 |
| 25 | MP0001849_ear_inflammation | 1.72999367 |
| 26 | MP0000609_abnormal_liver_physiology | 1.71923066 |
| 27 | MP0009643_abnormal_urine_homeostasis | 1.70947729 |
| 28 | MP0005058_abnormal_lysosome_morphology | 1.69752328 |
| 29 | MP0003329_amyloid_beta_deposits | 1.67222227 |
| 30 | MP0000751_myopathy | 1.66826125 |
| 31 | MP0003186_abnormal_redox_activity | 1.66427367 |
| 32 | MP0005083_abnormal_biliary_tract | 1.65896920 |
| 33 | MP0005319_abnormal_enzyme/_coenzyme | 1.63145294 |
| 34 | MP0003724_increased_susceptibility_to | 1.62594475 |
| 35 | MP0003950_abnormal_plasma_membrane | 1.56838202 |
| 36 | MP0002896_abnormal_bone_mineralization | 1.54164116 |
| 37 | MP0002118_abnormal_lipid_homeostasis | 1.52481725 |
| 38 | MP0010030_abnormal_orbit_morphology | 1.51203326 |
| 39 | MP0001958_emphysema | 1.45550212 |
| 40 | MP0004272_abnormal_basement_membrane | 1.44724274 |
| 41 | MP0001915_intracranial_hemorrhage | 1.43493779 |
| 42 | MP0009780_abnormal_chondrocyte_physiolo | 1.41185740 |
| 43 | MP0001756_abnormal_urination | 1.37320435 |
| 44 | MP0000537_abnormal_urethra_morphology | 1.37138248 |
| 45 | MP0010234_abnormal_vibrissa_follicle | 1.35416953 |
| 46 | MP0005275_abnormal_skin_tensile | 1.33285969 |
| 47 | MP0004233_abnormal_muscle_weight | 1.30352554 |
| 48 | MP0003279_aneurysm | 1.29685538 |
| 49 | MP0009384_cardiac_valve_regurgitation | 1.29209460 |
| 50 | MP0000534_abnormal_ureter_morphology | 1.26885534 |
| 51 | MP0000858_altered_metastatic_potential | 1.23574230 |
| 52 | MP0005197_abnormal_uvea_morphology | 1.23141899 |
| 53 | MP0006054_spinal_hemorrhage | 1.23027718 |
| 54 | MP0001542_abnormal_bone_strength | 1.20170241 |
| 55 | MP0005670_abnormal_white_adipose | 1.19331757 |
| 56 | MP0005377_hearing/vestibular/ear_phenot | 1.19132416 |
| 57 | MP0003878_abnormal_ear_physiology | 1.19132416 |
| 58 | MP0001661_extended_life_span | 1.18931023 |
| 59 | MP0003656_abnormal_erythrocyte_physiolo | 1.15872036 |
| 60 | MP0003172_abnormal_lysosome_physiology | 1.12673078 |
| 61 | MP0000598_abnormal_liver_morphology | 1.12187757 |
| 62 | MP0003718_maternal_effect | 1.11841810 |
| 63 | MP0002089_abnormal_postnatal_growth/wei | 1.10916797 |
| 64 | MP0005451_abnormal_body_composition | 1.10857082 |
| 65 | MP0003566_abnormal_cell_adhesion | 1.10182628 |
| 66 | MP0001764_abnormal_homeostasis | 1.07471137 |
| 67 | MP0003123_paternal_imprinting | 1.06812751 |
| 68 | MP0005503_abnormal_tendon_morphology | 1.05146399 |
| 69 | MP0005167_abnormal_blood-brain_barrier | 1.03074264 |
| 70 | MP0000762_abnormal_tongue_morphology | 1.02601753 |
| 71 | MP0002136_abnormal_kidney_physiology | 1.02500648 |
| 72 | MP0000003_abnormal_adipose_tissue | 1.00761285 |
| 73 | MP0005023_abnormal_wound_healing | 0.99688049 |
| 74 | MP0005636_abnormal_mineral_homeostasis | 0.98216380 |
| 75 | MP0009053_abnormal_anal_canal | 0.96696608 |
| 76 | MP0008004_abnormal_stomach_pH | 0.94844875 |
| 77 | MP0005395_other_phenotype | 0.94172425 |
| 78 | MP0005076_abnormal_cell_differentiation | 0.94142571 |
| 79 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.94135255 |
| 80 | MP0008469_abnormal_protein_level | 0.93806316 |
| 81 | MP0003183_abnormal_peptide_metabolism | 0.93112446 |
| 82 | MP0005084_abnormal_gallbladder_morpholo | 0.93026363 |
| 83 | MP0003385_abnormal_body_wall | 0.92803552 |
| 84 | MP0003300_gastrointestinal_ulcer | 0.92717679 |
| 85 | MP0005220_abnormal_exocrine_pancreas | 0.92281324 |
| 86 | MP0002060_abnormal_skin_morphology | 0.91157193 |
| 87 | MP0003075_altered_response_to | 0.89733431 |
| 88 | MP0001879_abnormal_lymphatic_vessel | 0.89329253 |
| 89 | MP0003941_abnormal_skin_development | 0.89324039 |
| 90 | MP0009764_decreased_sensitivity_to | 0.89271001 |
| 91 | MP0002998_abnormal_bone_remodeling | 0.88177299 |
| 92 | MP0005501_abnormal_skin_physiology | 0.87169439 |
| 93 | MP0005666_abnormal_adipose_tissue | 0.87124651 |
| 94 | MP0003634_abnormal_glial_cell | 0.85269964 |
| 95 | MP0001533_abnormal_skeleton_physiology | 0.84476094 |
| 96 | MP0000343_altered_response_to | 0.84278909 |
| 97 | MP0000733_abnormal_muscle_development | 0.82812825 |
| 98 | MP0005330_cardiomyopathy | 0.82449782 |
| 99 | MP0001614_abnormal_blood_vessel | 0.81638109 |
| 100 | MP0005193_abnormal_anterior_eye | 0.81524832 |
| 101 | MP0008260_abnormal_autophagy | 0.81254214 |
| 102 | MP0003868_abnormal_feces_composition | 0.80552382 |
| 103 | MP0002254_reproductive_system_inflammat | 0.80052976 |
| 104 | MP0000467_abnormal_esophagus_morphology | 0.79099250 |
| 105 | MP0003942_abnormal_urinary_system | 0.78830889 |
| 106 | MP0002295_abnormal_pulmonary_circulatio | 0.78688768 |
| 107 | MP0003115_abnormal_respiratory_system | 0.76663925 |
| 108 | MP0005621_abnormal_cell_physiology | 0.75996185 |
| 109 | MP0005397_hematopoietic_system_phenotyp | 0.75963387 |
| 110 | MP0001545_abnormal_hematopoietic_system | 0.75963387 |
| 111 | MP0002796_impaired_skin_barrier | 0.75768358 |
| 112 | MP0005595_abnormal_vascular_smooth | 0.74887624 |
| 113 | MP0000767_abnormal_smooth_muscle | 0.74239987 |
| 114 | MP0004782_abnormal_surfactant_physiolog | 0.73814112 |
| 115 | MP0004130_abnormal_muscle_cell | 0.72655683 |
| 116 | MP0001299_abnormal_eye_distance/ | 0.72559548 |
| 117 | MP0002092_abnormal_eye_morphology | 0.72177800 |
| 118 | MP0000013_abnormal_adipose_tissue | 0.71997977 |
| 119 | MP0004264_abnormal_extraembryonic_tissu | 0.71771789 |
| 120 | MP0001853_heart_inflammation | 0.71739035 |
| 121 | MP0005164_abnormal_response_to | 0.71398863 |
| 122 | MP0000249_abnormal_blood_vessel | 0.71337363 |
| 123 | MP0009763_increased_sensitivity_to | 0.70672174 |
| 124 | MP0002128_abnormal_blood_circulation | 0.70605501 |
| 125 | MP0003828_pulmonary_edema | 0.70570420 |
| 126 | MP0000462_abnormal_digestive_system | 0.69981752 |
| 127 | MP0003011_delayed_dark_adaptation | 0.69113767 |
| 128 | MP0003436_decreased_susceptibility_to | 0.69013671 |
| 129 | MP0002168_other_aberrant_phenotype | 0.68996663 |
| 130 | MP0006082_CNS_inflammation | 0.68671617 |
| 131 | MP0009642_abnormal_blood_homeostasis | 0.68413158 |
| 132 | MP0003315_abnormal_perineum_morphology | 0.67835135 |
| 133 | MP0010630_abnormal_cardiac_muscle | 0.67313157 |
| 134 | MP0000747_muscle_weakness | 0.66563210 |
| 135 | MP0010352_gastrointestinal_tract_polyps | 0.65799228 |
| 136 | MP0005508_abnormal_skeleton_morphology | 0.65628846 |
| 137 | MP0002135_abnormal_kidney_morphology | 0.64506580 |
| 138 | MP0000371_diluted_coat_color | 0.64471742 |
| 139 | MP0002113_abnormal_skeleton_development | 0.63973215 |
| 140 | MP0000604_amyloidosis | 0.63811731 |
| 141 | MP0000750_abnormal_muscle_regeneration | 0.63795775 |
| 142 | MP0006138_congestive_heart_failure | 0.63689148 |
| 143 | MP0003453_abnormal_keratinocyte_physiol | 0.62777759 |
| 144 | MP0005390_skeleton_phenotype | 0.62356785 |
| 145 | MP0004947_skin_inflammation | 0.62054583 |
| 146 | MP0000681_abnormal_thyroid_gland | 0.61723176 |
| 147 | MP0000163_abnormal_cartilage_morphology | 0.61696139 |
| 148 | MP0001243_abnormal_dermal_layer | 0.61094089 |
| 149 | MP0005408_hypopigmentation | 0.61048560 |
| 150 | MP0005464_abnormal_platelet_physiology | 0.60220306 |
| 151 | MP0005165_increased_susceptibility_to | 0.59817057 |
| 152 | MP0009278_abnormal_bone_marrow | 0.59649166 |
| 153 | MP0002971_abnormal_brown_adipose | 0.59365513 |
| 154 | MP0005647_abnormal_sex_gland | 0.58641854 |
| 155 | MP0002877_abnormal_melanocyte_morpholog | 0.57158077 |
| 156 | MP0009115_abnormal_fat_cell | 0.56740948 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperglycinuria (HP:0003108) | 4.74010716 |
| 2 | Hyperglycinemia (HP:0002154) | 4.46392650 |
| 3 | Xanthomatosis (HP:0000991) | 4.39289041 |
| 4 | Deep venous thrombosis (HP:0002625) | 4.34168957 |
| 5 | Gout (HP:0001997) | 4.28419025 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.16998189 |
| 7 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.14867786 |
| 8 | Abnormality of glycine metabolism (HP:0010895) | 4.14867786 |
| 9 | Intrahepatic cholestasis (HP:0001406) | 3.83945004 |
| 10 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.79911421 |
| 11 | Premature rupture of membranes (HP:0001788) | 3.55074625 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 3.46580248 |
| 13 | Arterial tortuosity (HP:0005116) | 3.34708287 |
| 14 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.33061803 |
| 15 | Hypobetalipoproteinemia (HP:0003563) | 3.29927783 |
| 16 | Vascular tortuosity (HP:0004948) | 3.28322547 |
| 17 | Hyperammonemia (HP:0001987) | 3.27389755 |
| 18 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.23281998 |
| 19 | Prolonged partial thromboplastin time (HP:0003645) | 3.20951811 |
| 20 | Complement deficiency (HP:0004431) | 3.15956460 |
| 21 | Hypoalphalipoproteinemia (HP:0003233) | 3.10015337 |
| 22 | Hypoglycemic coma (HP:0001325) | 3.06320199 |
| 23 | Hypolipoproteinemia (HP:0010981) | 3.05744898 |
| 24 | Abnormality of purine metabolism (HP:0004352) | 3.05641328 |
| 25 | Polycythemia (HP:0001901) | 2.97508456 |
| 26 | Abnormality of the intrinsic pathway (HP:0010989) | 2.97231041 |
| 27 | Flat acetabular roof (HP:0003180) | 2.87695808 |
| 28 | Distal upper limb amyotrophy (HP:0007149) | 2.87619658 |
| 29 | Upper limb amyotrophy (HP:0009129) | 2.87619658 |
| 30 | Atrophic scars (HP:0001075) | 2.85432390 |
| 31 | Aortic dissection (HP:0002647) | 2.83946162 |
| 32 | Protrusio acetabuli (HP:0003179) | 2.81621487 |
| 33 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.79462896 |
| 34 | Abnormality of the common coagulation pathway (HP:0010990) | 2.79092655 |
| 35 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.76562206 |
| 36 | Abnormality of serum amino acid levels (HP:0003112) | 2.72987709 |
| 37 | Increased purine levels (HP:0004368) | 2.72015030 |
| 38 | Hyperuricemia (HP:0002149) | 2.72015030 |
| 39 | Wormian bones (HP:0002645) | 2.71883413 |
| 40 | Myocardial infarction (HP:0001658) | 2.70945780 |
| 41 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.67435938 |
| 42 | Nonimmune hydrops fetalis (HP:0001790) | 2.60274162 |
| 43 | Systemic lupus erythematosus (HP:0002725) | 2.60169613 |
| 44 | Spinal rigidity (HP:0003306) | 2.59141724 |
| 45 | Distal lower limb amyotrophy (HP:0008944) | 2.57617885 |
| 46 | Osteolytic defects of the hand bones (HP:0009699) | 2.57047563 |
| 47 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.57047563 |
| 48 | Ketosis (HP:0001946) | 2.56487441 |
| 49 | Abnormality of carpal bone ossification (HP:0006257) | 2.55862228 |
| 50 | Abnormality of nucleobase metabolism (HP:0010932) | 2.55769352 |
| 51 | Abnormal cartilage morphology (HP:0002763) | 2.54253016 |
| 52 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.54194980 |
| 53 | Dicarboxylic aciduria (HP:0003215) | 2.54194980 |
| 54 | Joint hemorrhage (HP:0005261) | 2.52363707 |
| 55 | Cardiovascular calcification (HP:0011915) | 2.51384725 |
| 56 | Vascular calcification (HP:0004934) | 2.50972489 |
| 57 | Hand muscle atrophy (HP:0009130) | 2.50936179 |
| 58 | Fat malabsorption (HP:0002630) | 2.50406411 |
| 59 | Hyperacusis (HP:0010780) | 2.49656128 |
| 60 | Abnormality of complement system (HP:0005339) | 2.49645563 |
| 61 | Abnormality of the acetabulum (HP:0003170) | 2.48133621 |
| 62 | Generalized aminoaciduria (HP:0002909) | 2.45719432 |
| 63 | Esophageal varix (HP:0002040) | 2.45599596 |
| 64 | Distal lower limb muscle weakness (HP:0009053) | 2.44727760 |
| 65 | Abnormality of dentin (HP:0010299) | 2.37725162 |
| 66 | Abnormal ossification of hand bones (HP:0005921) | 2.35477119 |
| 67 | Shallow orbits (HP:0000586) | 2.35202601 |
| 68 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.34099573 |
| 69 | Ankle contracture (HP:0006466) | 2.34008446 |
| 70 | Ulnar bowing (HP:0003031) | 2.32729214 |
| 71 | Pustule (HP:0200039) | 2.32292519 |
| 72 | Bladder diverticulum (HP:0000015) | 2.30831112 |
| 73 | Alopecia of scalp (HP:0002293) | 2.28946081 |
| 74 | Nausea (HP:0002018) | 2.27749885 |
| 75 | Vacuolated lymphocytes (HP:0001922) | 2.26638821 |
| 76 | Neurofibrillary tangles (HP:0002185) | 2.26389757 |
| 77 | Blue sclerae (HP:0000592) | 2.26345216 |
| 78 | Abnormality of proline metabolism (HP:0010907) | 2.26143849 |
| 79 | Hydroxyprolinuria (HP:0003080) | 2.26143849 |
| 80 | Back pain (HP:0003418) | 2.24204214 |
| 81 | Fragile skin (HP:0001030) | 2.23753838 |
| 82 | Neonatal short-limb short stature (HP:0008921) | 2.22407939 |
| 83 | Increased connective tissue (HP:0009025) | 2.20859949 |
| 84 | Mitral regurgitation (HP:0001653) | 2.19530921 |
| 85 | Cervical subluxation (HP:0003308) | 2.18357039 |
| 86 | Amyloidosis (HP:0011034) | 2.18182889 |
| 87 | Menorrhagia (HP:0000132) | 2.18035218 |
| 88 | Broad face (HP:0000283) | 2.17584151 |
| 89 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.17184917 |
| 90 | Hyperglycemia (HP:0003074) | 2.16097159 |
| 91 | Coxa vara (HP:0002812) | 2.15489030 |
| 92 | Proximal tubulopathy (HP:0000114) | 2.15283476 |
| 93 | Achilles tendon contracture (HP:0001771) | 2.15169439 |
| 94 | Hypercholesterolemia (HP:0003124) | 2.14704142 |
| 95 | Short nail (HP:0001799) | 2.14303591 |
| 96 | Glomerulonephritis (HP:0000099) | 2.13671215 |
| 97 | Epidermoid cyst (HP:0200040) | 2.13349775 |
| 98 | Hepatocellular carcinoma (HP:0001402) | 2.11806885 |
| 99 | Abnormality of the Achilles tendon (HP:0005109) | 2.11183365 |
| 100 | Cerebral inclusion bodies (HP:0100314) | 2.09875645 |
| 101 | Lethargy (HP:0001254) | 2.06628737 |
| 102 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.04037991 |
| 103 | Axonal loss (HP:0003447) | 2.02721322 |
| 104 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.00031772 |
| 105 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.00031772 |
| 106 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.00031772 |
| 107 | Irritability (HP:0000737) | 1.99463595 |
| 108 | Aneurysm (HP:0002617) | 1.98287761 |
| 109 | Abnormality of methionine metabolism (HP:0010901) | 1.97602002 |
| 110 | Nephritis (HP:0000123) | 1.97245944 |
| 111 | Ketoacidosis (HP:0001993) | 1.96298035 |
| 112 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.95732760 |
| 113 | Abnormality of glycolipid metabolism (HP:0010969) | 1.95732760 |
| 114 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.95732760 |
| 115 | Steatorrhea (HP:0002570) | 1.95477900 |
| 116 | Chondrocalcinosis (HP:0000934) | 1.94411588 |
| 117 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.93629907 |
| 118 | Malnutrition (HP:0004395) | 1.92939323 |
| 119 | Right ventricular cardiomyopathy (HP:0011663) | 1.92855892 |
| 120 | Mitral stenosis (HP:0001718) | 1.92215182 |
| 121 | Dilatation of the ascending aorta (HP:0005111) | 1.90967209 |
| 122 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.90165130 |
| 123 | Asymmetry of the thorax (HP:0001555) | 1.89479919 |
| 124 | Atrioventricular block (HP:0001678) | 1.89314859 |
| 125 | Elbow flexion contracture (HP:0002987) | 1.87694972 |
| 126 | Beaking of vertebral bodies (HP:0004568) | 1.87060740 |
| 127 | Natal tooth (HP:0000695) | 1.87037992 |
| 128 | Delayed CNS myelination (HP:0002188) | 1.86910048 |
| 129 | Interstitial pulmonary disease (HP:0006530) | 1.86458533 |
| 130 | Aortic aneurysm (HP:0004942) | 1.86399707 |
| 131 | Disproportionate tall stature (HP:0001519) | 1.85832633 |
| 132 | J-shaped sella turcica (HP:0002680) | 1.85572923 |
| 133 | Abnormal hand bone ossification (HP:0010660) | 1.85232494 |
| 134 | Joint laxity (HP:0001388) | 1.85222528 |
| 135 | Abnormal delivery (HP:0001787) | 1.84407395 |
| 136 | Skin nodule (HP:0200036) | 1.84372023 |
| 137 | Multiple enchondromatosis (HP:0005701) | 1.83564578 |
| 138 | Biconcave vertebral bodies (HP:0004586) | 1.83416452 |
| 139 | Hypoplasia of the iris (HP:0007676) | 1.82833607 |
| 140 | Vertebral compression fractures (HP:0002953) | 1.82622156 |
| 141 | Protuberant abdomen (HP:0001538) | 1.81540208 |
| 142 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.80584967 |
| 143 | Vertebral hypoplasia (HP:0008417) | 1.80584967 |
| 144 | Spastic diplegia (HP:0001264) | 1.80113214 |
| 145 | Muscle fiber splitting (HP:0003555) | 1.79914567 |
| 146 | Hemorrhage of the eye (HP:0011885) | 1.79101095 |
| 147 | Nuclear cataract (HP:0100018) | 1.78896669 |
| 148 | Soft skin (HP:0000977) | 1.77570496 |
| 149 | Peritonitis (HP:0002586) | 1.77539477 |
| 150 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.76872549 |
| 151 | Lower limb amyotrophy (HP:0007210) | 1.76710730 |
| 152 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.76497812 |
| 153 | Cupped ribs (HP:0000887) | 1.76275135 |
| 154 | Cerebral aneurysm (HP:0004944) | 1.75197175 |
| 155 | Joint stiffness (HP:0001387) | 1.75007854 |
| 156 | Conjugated hyperbilirubinemia (HP:0002908) | 1.74963597 |
| 157 | Dysostosis multiplex (HP:0000943) | 1.74689292 |
| 158 | Hyperbilirubinemia (HP:0002904) | 1.72750408 |
| 159 | Abnormality of Sharpey fibers (HP:0100685) | 1.72224751 |
| 160 | Metabolic acidosis (HP:0001942) | 1.71845649 |
| 161 | Stroke (HP:0001297) | 1.70810988 |
| 162 | Thin bony cortex (HP:0002753) | 1.70414309 |
| 163 | Hyperextensible skin (HP:0000974) | 1.70388334 |
| 164 | Mucopolysacchariduria (HP:0008155) | 1.70045395 |
| 165 | Long toe (HP:0010511) | 1.69952630 |
| 166 | Difficulty climbing stairs (HP:0003551) | 1.69860543 |
| 167 | Purpura (HP:0000979) | 1.69116042 |
| 168 | Flattened epiphyses (HP:0003071) | 1.69110298 |
| 169 | Vertebral arch anomaly (HP:0008438) | 1.69032444 |
| 170 | Ovoid vertebral bodies (HP:0003300) | 1.68536296 |
| 171 | Growth hormone excess (HP:0000845) | 1.66031963 |
| 172 | Spondylolisthesis (HP:0003302) | 1.65435916 |
| 173 | Renal duplication (HP:0000075) | 1.65227132 |
| 174 | Insomnia (HP:0100785) | 1.65153106 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.87393821 |
| 2 | TRIB3 | 3.75370645 |
| 3 | BCKDK | 3.40591972 |
| 4 | TESK1 | 3.20653087 |
| 5 | EPHA2 | 2.81675692 |
| 6 | ICK | 2.60270657 |
| 7 | TIE1 | 2.58569936 |
| 8 | KDR | 2.26545537 |
| 9 | LIMK1 | 2.24259744 |
| 10 | TGFBR2 | 2.14338706 |
| 11 | LMTK2 | 2.13431234 |
| 12 | FGFR4 | 2.11601836 |
| 13 | NME2 | 2.08206694 |
| 14 | TESK2 | 2.00263583 |
| 15 | MAP3K3 | 1.94772121 |
| 16 | NTRK1 | 1.92860701 |
| 17 | BUB1 | 1.89486261 |
| 18 | LATS1 | 1.87279553 |
| 19 | STK38L | 1.83971614 |
| 20 | PDK2 | 1.83257928 |
| 21 | SIK1 | 1.81738770 |
| 22 | ACVR1B | 1.75215492 |
| 23 | MST1R | 1.75159489 |
| 24 | NEK9 | 1.69945466 |
| 25 | PKN2 | 1.68091715 |
| 26 | AKT3 | 1.65795088 |
| 27 | STK3 | 1.63124990 |
| 28 | SCYL2 | 1.62251980 |
| 29 | PIM2 | 1.57866645 |
| 30 | IRAK3 | 1.56110099 |
| 31 | SMG1 | 1.50838946 |
| 32 | PRPF4B | 1.45830522 |
| 33 | PDK4 | 1.41077811 |
| 34 | PDK3 | 1.41077811 |
| 35 | TTN | 1.36997381 |
| 36 | RPS6KA4 | 1.31850967 |
| 37 | PTK6 | 1.31273793 |
| 38 | TBK1 | 1.28457511 |
| 39 | WEE1 | 1.27940081 |
| 40 | LRRK2 | 1.25717987 |
| 41 | MAP2K2 | 1.18064232 |
| 42 | DDR2 | 1.17425322 |
| 43 | MAP2K3 | 1.15191282 |
| 44 | PDGFRA | 1.15036153 |
| 45 | MAP3K6 | 1.09340006 |
| 46 | TYK2 | 1.09264802 |
| 47 | PAK4 | 1.08935847 |
| 48 | TAOK2 | 1.08426519 |
| 49 | MYLK | 1.05620859 |
| 50 | EPHB1 | 1.05036772 |
| 51 | ABL2 | 1.02589270 |
| 52 | EIF2AK1 | 1.00640608 |
| 53 | FLT3 | 1.00118645 |
| 54 | STK38 | 0.99929865 |
| 55 | PTK2 | 0.98460543 |
| 56 | BRSK2 | 0.98420665 |
| 57 | MET | 0.97404337 |
| 58 | NUAK1 | 0.96611551 |
| 59 | STK10 | 0.95831874 |
| 60 | FRK | 0.95039376 |
| 61 | RIPK1 | 0.91617852 |
| 62 | ERBB4 | 0.88620196 |
| 63 | TGFBR1 | 0.88053818 |
| 64 | RET | 0.86888293 |
| 65 | PAK2 | 0.82666492 |
| 66 | ROCK2 | 0.82441144 |
| 67 | NEK2 | 0.81730511 |
| 68 | LATS2 | 0.81296952 |
| 69 | TSSK6 | 0.79159111 |
| 70 | PRKD2 | 0.77245553 |
| 71 | KSR2 | 0.76882180 |
| 72 | ILK | 0.75901123 |
| 73 | CDK12 | 0.75269012 |
| 74 | CDC42BPA | 0.74901912 |
| 75 | PIK3CG | 0.74649248 |
| 76 | MAP3K2 | 0.73290286 |
| 77 | PINK1 | 0.73195552 |
| 78 | PDGFRB | 0.72919161 |
| 79 | TAOK3 | 0.72071245 |
| 80 | EPHB2 | 0.69685596 |
| 81 | MAPK11 | 0.69090525 |
| 82 | MAPKAPK3 | 0.68642156 |
| 83 | PBK | 0.67225597 |
| 84 | MAP2K1 | 0.66739488 |
| 85 | KIT | 0.66061567 |
| 86 | JAK1 | 0.66013979 |
| 87 | DMPK | 0.65256029 |
| 88 | RPS6KA2 | 0.64663873 |
| 89 | ZAK | 0.63326754 |
| 90 | ZAP70 | 0.63232529 |
| 91 | MAP3K1 | 0.60908104 |
| 92 | JAK2 | 0.59261004 |
| 93 | EEF2K | 0.59200912 |
| 94 | WNK4 | 0.58814337 |
| 95 | NEK1 | 0.58390319 |
| 96 | CDK6 | 0.58289037 |
| 97 | CDK7 | 0.58281234 |
| 98 | GSK3A | 0.57651423 |
| 99 | MAP3K8 | 0.57509628 |
| 100 | FGFR3 | 0.57119863 |
| 101 | FER | 0.56209592 |
| 102 | JAK3 | 0.55392001 |
| 103 | MTOR | 0.54064182 |
| 104 | TYRO3 | 0.54000903 |
| 105 | WNK3 | 0.53046158 |
| 106 | MAP3K11 | 0.52874506 |
| 107 | MAPK15 | 0.52321576 |
| 108 | EPHA3 | 0.50216162 |
| 109 | EIF2AK3 | 0.49886013 |
| 110 | DYRK3 | 0.49391787 |
| 111 | BMX | 0.48987810 |
| 112 | PLK4 | 0.47724953 |
| 113 | STK24 | 0.47333696 |
| 114 | TRPM7 | 0.46798865 |
| 115 | DYRK1B | 0.45432157 |
| 116 | MAP3K12 | 0.45129600 |
| 117 | PRKD3 | 0.44524782 |
| 118 | CSK | 0.43919115 |
| 119 | CDK8 | 0.43227943 |
| 120 | SRC | 0.42867563 |
| 121 | PIM1 | 0.42850215 |
| 122 | PRKD1 | 0.42030171 |
| 123 | ARAF | 0.41452824 |
| 124 | MOS | 0.40875639 |
| 125 | PRKAA1 | 0.40669096 |
| 126 | CDK14 | 0.40543430 |
| 127 | PRKAA2 | 0.40201120 |
| 128 | ROCK1 | 0.39537749 |
| 129 | GRK1 | 0.39396528 |
| 130 | IKBKB | 0.39224979 |
| 131 | PDPK1 | 0.39001951 |
| 132 | PAK1 | 0.38904310 |
| 133 | PRKG2 | 0.38474034 |
| 134 | CDK4 | 0.38106789 |
| 135 | CAMK2G | 0.37483746 |
| 136 | CDK9 | 0.37008662 |
| 137 | MARK2 | 0.35780896 |
| 138 | CDK15 | 0.35753348 |
| 139 | INSRR | 0.35722561 |
| 140 | NLK | 0.35475036 |
| 141 | CDK11A | 0.34807728 |
| 142 | AKT2 | 0.34697411 |
| 143 | TAOK1 | 0.34444376 |
| 144 | CDK18 | 0.34085320 |
| 145 | MAPKAPK2 | 0.33756165 |
| 146 | CHUK | 0.32577571 |
| 147 | PAK6 | 0.31615463 |
| 148 | DAPK3 | 0.31143922 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 3.14914418 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.97418104 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.92026186 |
| 4 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.58034801 |
| 5 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.54056462 |
| 6 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.51553583 |
| 7 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.49698978 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.48186760 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.48063965 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.37276523 |
| 11 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.26303219 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.17544084 |
| 13 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 2.11078960 |
| 14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.06389417 |
| 15 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.95360126 |
| 16 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.94759099 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.91009037 |
| 18 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.87409587 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.86423321 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 1.80132376 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.80109674 |
| 22 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.75520147 |
| 23 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.75040333 |
| 24 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.72561798 |
| 25 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.72271867 |
| 26 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.71857279 |
| 27 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.70694361 |
| 28 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.70054754 |
| 29 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.69236735 |
| 30 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.63047798 |
| 31 | Adherens junction_Homo sapiens_hsa04520 | 1.59708735 |
| 32 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.57333189 |
| 33 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.53982880 |
| 34 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.53466638 |
| 35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.51858383 |
| 36 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.50992446 |
| 37 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.45360927 |
| 38 | Histidine metabolism_Homo sapiens_hsa00340 | 1.42943472 |
| 39 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.41949923 |
| 40 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.39448252 |
| 41 | Retinol metabolism_Homo sapiens_hsa00830 | 1.39441522 |
| 42 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.39369943 |
| 43 | Sulfur relay system_Homo sapiens_hsa04122 | 1.38013734 |
| 44 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.37931981 |
| 45 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.36635530 |
| 46 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.34460034 |
| 47 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.28521172 |
| 48 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.27673214 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.27365092 |
| 50 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.26480449 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.25530046 |
| 52 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.23812687 |
| 53 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.22538447 |
| 54 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.22206975 |
| 55 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.20644658 |
| 56 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.19880976 |
| 57 | Thyroid cancer_Homo sapiens_hsa05216 | 1.18700926 |
| 58 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.16068192 |
| 59 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.14102031 |
| 60 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.13817348 |
| 61 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.11737404 |
| 62 | Bile secretion_Homo sapiens_hsa04976 | 1.09925207 |
| 63 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.09665096 |
| 64 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.08089233 |
| 65 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.06820165 |
| 66 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.06037434 |
| 67 | Shigellosis_Homo sapiens_hsa05131 | 1.03273171 |
| 68 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.01760562 |
| 69 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.00929548 |
| 70 | Endometrial cancer_Homo sapiens_hsa05213 | 1.00154728 |
| 71 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.99831898 |
| 72 | Endocytosis_Homo sapiens_hsa04144 | 0.98452308 |
| 73 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.95873316 |
| 74 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.95246681 |
| 75 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.94998492 |
| 76 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.93238485 |
| 77 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.92942837 |
| 78 | Salmonella infection_Homo sapiens_hsa05132 | 0.92264209 |
| 79 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.92112648 |
| 80 | Lysosome_Homo sapiens_hsa04142 | 0.92008180 |
| 81 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.90776848 |
| 82 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.90168796 |
| 83 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.89539614 |
| 84 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.88863567 |
| 85 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.87918259 |
| 86 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.86689149 |
| 87 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.81932355 |
| 88 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.78603956 |
| 89 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.78517936 |
| 90 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.78252297 |
| 91 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.76215208 |
| 92 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.75777882 |
| 93 | Tight junction_Homo sapiens_hsa04530 | 0.72840222 |
| 94 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.71492672 |
| 95 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.70778878 |
| 96 | ABC transporters_Homo sapiens_hsa02010 | 0.70511424 |
| 97 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.69431855 |
| 98 | Phagosome_Homo sapiens_hsa04145 | 0.69365973 |
| 99 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.67262792 |
| 100 | Other glycan degradation_Homo sapiens_hsa00511 | 0.67121588 |
| 101 | Axon guidance_Homo sapiens_hsa04360 | 0.65724811 |
| 102 | Galactose metabolism_Homo sapiens_hsa00052 | 0.64937842 |
| 103 | Pertussis_Homo sapiens_hsa05133 | 0.64416364 |
| 104 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.63503383 |
| 105 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.62605113 |
| 106 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.62541413 |
| 107 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.62474786 |
| 108 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.62316512 |
| 109 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.59852966 |
| 110 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.59284186 |
| 111 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.58655622 |
| 112 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.58537397 |
| 113 | Pathways in cancer_Homo sapiens_hsa05200 | 0.58233554 |
| 114 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.58040266 |
| 115 | Glioma_Homo sapiens_hsa05214 | 0.57755714 |
| 116 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.57252469 |
| 117 | Gap junction_Homo sapiens_hsa04540 | 0.55787099 |
| 118 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.54692764 |
| 119 | Hepatitis C_Homo sapiens_hsa05160 | 0.54114693 |
| 120 | Mineral absorption_Homo sapiens_hsa04978 | 0.52713343 |
| 121 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.51403170 |
| 122 | Apoptosis_Homo sapiens_hsa04210 | 0.51249059 |
| 123 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49565892 |
| 124 | Prostate cancer_Homo sapiens_hsa05215 | 0.48367628 |
| 125 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.48177549 |
| 126 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.47781196 |
| 127 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.47742664 |
| 128 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.46942332 |
| 129 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45116493 |
| 130 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.44414567 |
| 131 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.44214584 |
| 132 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.42233154 |
| 133 | Lysine degradation_Homo sapiens_hsa00310 | 0.41218991 |
| 134 | Melanogenesis_Homo sapiens_hsa04916 | 0.40749540 |
| 135 | Legionellosis_Homo sapiens_hsa05134 | 0.40563742 |
| 136 | Insulin resistance_Homo sapiens_hsa04931 | 0.39386922 |
| 137 | Colorectal cancer_Homo sapiens_hsa05210 | 0.39207420 |
| 138 | Malaria_Homo sapiens_hsa05144 | 0.37491112 |
| 139 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.36605668 |
| 140 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.34745412 |
| 141 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.32745565 |
| 142 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.32562210 |
| 143 | Prion diseases_Homo sapiens_hsa05020 | 0.30766786 |
| 144 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.27658982 |
| 145 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.25755769 |
| 146 | Bladder cancer_Homo sapiens_hsa05219 | 0.23709348 |
| 147 | Amoebiasis_Homo sapiens_hsa05146 | 0.22863277 |
| 148 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20883660 |
| 149 | Proteasome_Homo sapiens_hsa03050 | 0.18866452 |
| 150 | Focal adhesion_Homo sapiens_hsa04510 | 0.18000537 |
| 151 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.14889568 |
| 152 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.13948887 |
| 153 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.13546134 |
| 154 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.12878702 |
| 155 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.12327655 |
| 156 | RNA polymerase_Homo sapiens_hsa03020 | 0.10472305 |

